摘要
目的:本文主要研究骨化三醇(维生素D的活性激素代谢产物)对II型糖尿病中肝脏代谢异常的影响 方法:II型糖尿病db/db(隐形基因即不发病)小鼠用来研究骨化三醇对肝系统性代谢紊乱的影响。在胰岛素抵抗条件下培养的人肝癌细胞被用来测试在肝脏脂质和糖代谢中骨化三醇介导改变的机制。 结果:8周骨化三醇的治疗改善了db/db小鼠中异常肝脏脂质和糖质新生。对于胰岛素抵抗条件下培养的人肝癌细胞,骨化三醇增加了胞内游离钙的浓度并通过钙/钙调蛋白依赖性蛋白激酶(CaMKKβ)通路诱导5’-腺苷酸活化蛋白激酶磷酸化,有助于减少肝甘油三酯的积累和葡萄糖的输出。骨化三醇也诱导了db/db小鼠肝脏中5’-腺苷酸活化蛋白激酶磷酸化。
关键词: 钙;人肝癌细胞;脂肪生成;糖质新生;非酒精性脂肪性肝病;维生素D
Current Molecular Medicine
Title:Calcitriol Reduces Hepatic Triglyceride Accumulation and Glucose Output Through Ca2+/CaMKKβ/AMPK Activation Under Insulin-Resistant Conditions in Type 2 Diabetes Mellitus
Volume: 16 Issue: 8
Author(s): S. Cheng, W. Y. So, D. Zhang, Q. Cheng, B. J. Boucher, P. S. Leung
Affiliation:
关键词: 钙;人肝癌细胞;脂肪生成;糖质新生;非酒精性脂肪性肝病;维生素D
摘要: Objectives: The present study was designed to investigate the effects of calcitriol (the active hormonal metabolite of vitamin D) on hepatic metabolic abnormalities in type 2 diabetes.
Methods: Type 2 diabetic db/db mice were used to investigate the effects of calcitriol on hepatic and systemic metabolic disorders. HepG2 cells cultured in insulin-resistant conditions were used to examine the potential mechanisms for calcitriol-induced changes in hepatic lipid and glucose metabolism.
Results: 8-week calcitriol treatment ameliorated abnormal hepatic lipid and glucose production in db/db mice. In HepG2 cells under insulin-resistant condition, calcitriol increased cytosolic calcium concentration and induced 5’-AMP-activated protein kinase/acetyl-CoAcarboxylase (AMPK/ACC) phosphorylation via the Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) pathway, contributing to the reductions in hepatic triglyceride accumulation and glucose output. Calcitriol also induced AMPK/ACC phosphorylation in liver of db/db mice.
Conclusion: Our data indicate that calcitriol, at above-physiological serum concentrations, reduces hepatic triglyceride accumulation and glucose output, at least in part through activation of Ca2+/CaMKKβ/AMPK under insulin-resistant condition.
Export Options
About this article
Cite this article as:
S. Cheng, W. Y. So, D. Zhang, Q. Cheng, B. J. Boucher, P. S. Leung , Calcitriol Reduces Hepatic Triglyceride Accumulation and Glucose Output Through Ca2+/CaMKKβ/AMPK Activation Under Insulin-Resistant Conditions in Type 2 Diabetes Mellitus, Current Molecular Medicine 2016; 16 (8) . https://dx.doi.org/10.2174/1566524016666160920111407
DOI https://dx.doi.org/10.2174/1566524016666160920111407 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Microfluidics in Blood-Brain Barrier Permeability Cell Culture Modeling: Relevance to CNS Disorders
CNS & Neurological Disorders - Drug Targets Harnessing Stem Cell Potential for the Treatment of Erectile Function in Men with Diabetes Mellitus: From Preclinical/Clinical Perspectives to Penile Tissue Engineering
Current Stem Cell Research & Therapy Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
Current Vascular Pharmacology Screening GLP-1 Receptor Ligands from Natural Products in Herbs through High-Content Technique
Combinatorial Chemistry & High Throughput Screening Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria
Current Hypertension Reviews Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Endothelial Microparticles: Mediators or Markers of Endothelial Cell Dysfunction?
Current Hypertension Reviews Substance P at the Neuro-Immune Crosstalk in the Modulation of Inflammation, Asthma and Antimicrobial Host Defense
Inflammation & Allergy - Drug Targets (Discontinued) Effects of Lipid-Lowering Agents on Inflammation, Haemostasis and Blood Pressure
Current Pharmaceutical Design Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies
Current Drug Metabolism Nutritional Metabolomics: Lessons from Companion Animals
Current Metabolomics Antithrombotic Treatment in the Prevention of Ischemic Stroke
Current Drug Targets Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Current Medicinal Chemistry Assessment and Relevance of Carotid Intima-Media Thickness (C-IMT) in Primary and Secondary Cardiovascular Prevention
Current Pharmaceutical Design Why is the Incidence of Type 1 Diabetes Increasing?
Current Diabetes Reviews Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors
Current HIV Research Cardiac Stem Cell Characteristics in Physiological and Pathological Conditions
Current Pharmaceutical Design A Pre-Post Study of Vitamin D Supplement Effects on Urinary Megalin: The Emerging Predictive Role of Megalin in Diabetic Nephropathy Progression
Endocrine, Metabolic & Immune Disorders - Drug Targets